The promoting mechanism of TRU NIAGEN™ to be featured at the American Academy of Anti-Aging Medicine World Congress
December 04 2017 - 6:30AM
ChromaDex Corp. (NASDAQ:CDXC), a science-based, fully integrated
nutraceutical company devoted to extending human healthspan,
announced today it will feature its proprietary, anti-aging
nutrient TRU NIAGEN™ at the American Academy of Anti-Aging Medicine
(A4M) 25th Annual World Congress meeting, booth #8086 this December
14-16 in Las Vegas, NV.
Amy Sindler, PhD, a new member of the ChromaDex
scientific affairs team and nicotinamide adenine dinucleotide (NAD)
expert will be on site to talk to attendees about the exciting
mechanism of action that has ignited excitement among the
scientific community globally. Stop by to discuss the human
clinical evidence supporting its efficacy.
Research indicates that anti-aging benefits of TRU NIAGEN™
include:
- Increasing metabolism and energy production in every cell*
- Promotion of healthy mitochondrial function, which is an
important component of human aging*
- Increased sirtuin activation, improving mitochondrial activity
to help defend against cellular damage due to free radicals*
The booth will also host a book signing with
renowned neurosurgeon Joseph Maroon. Those who stop by may
receive one of the 250 free signed copies of Maroon’s book, “Square
One, A Simple Guide to a Balanced Life.” In this inspiring book
based on his deeply personal journey and documented science, Maroon
guides readers into improving their quality of life by rebalancing
four areas: good health, a sense of spirituality, meaningful work
and strong relationships.
At 77, this veteran of more than 70 triathlons
and nine Ironman triathlons is a living testament to all he’s
learned. Part of his daily regimen is to take a next-generation
form of vitamin B3 called TRU NIAGEN™, which helps to activate the
body’s healthy aging mechanisms. “The cells in our body can contain
anywhere from a few to thousands of mitochondria, which produce our
energy (ATP). If you don’t have enough ATP, your cells don’t
function properly. And if enough cells don’t function, you don’t
function. To stay healthy, your cells need NAD+. TRU NIAGEN™ is a
highly effective NAD+ booster,” comments Maroon, who says he feels
20 years younger than his chronological age.
Visitors to the booth will also have the chance
to receive a free full-size bottle of TRU NIAGEN™ as they take part
in a fun photo opportunity to share with the world why they are
working to help people Age Better. Attendees should plan to come
early as quantities are limited.
For additional information on the science
supporting TRU NIAGEN™, visit www.truniagen.com.
*These statements have not been evaluated by the Food and Drug
Administration. This product is not intended to diagnose, treat,
cure, or prevent any diseases.
About ChromaDex:
ChromaDex leverages its complementary business units to
discover, acquire, develop and commercialize patented and
proprietary health and wellness consumer products and ingredient
technologies that promote healthy aging. In addition to our
consumer product and ingredient technologies units, we also have
business units focused on natural product fine chemicals (known as
"phytochemicals"), and product regulatory and safety consulting. As
a result of our relationships with leading universities and
research institutions, we are able to discover and license early
stage, IP-backed ingredient technologies. We then utilize our
in-house chemistry, regulatory and safety consulting business units
to develop commercially viable ingredients. Our consumer product
and ingredient portfolio are backed with clinical and scientific
research, as well as extensive IP protection. Our portfolio of
patented ingredient technologies
includes NIAGEN® nicotinamide
riboside; pTeroPure® pterostilbene; PURENERGY®, a
caffeine-pTeroPure® co-crystal; IMMULINA™, a spirulina
extract; and AnthOrigin®, anthocyanins derived from a
domestically-produced, water-extracted purple corn husk. To learn
more about ChromaDex, please visit www.ChromaDex.com.
Forward-Looking Statements:
This release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities and Exchange Act of 1934, as
amended, including statements related to the significance of the
research and the anti-aging benefits of TRU NIAGEN™. Statements
that are not a description of historical facts constitute
forward-looking statements and may often, but not always, be
identified by the use of such words as "expects", "anticipates",
"intends", "estimates", "plans", "potential", "possible",
"probable", "believes", "seeks", "may", "will", "should", "could"
or the negative of such terms or other similar expressions. Actual
results may differ materially from those set forth in this release
due to the risks and uncertainties inherent in ChromaDex's
business. More detailed information about ChromaDex and the risk
factors that may affect the realization of forward-looking
statements is set forth in ChromaDex's Annual Report on Form 10-K
for the fiscal year ended December 31, 2016, ChromaDex's Quarter
Reports on Form 10-Q and other filings submitted by ChromaDex to
the SEC, copies of which may be obtained from the SEC's website at
www.sec.gov. Readers are cautioned not to place undue reliance on
these forward-looking statements, which speak only as of the date
hereof. All forward-looking statements are qualified in their
entirety by this cautionary statement and ChromaDex undertakes no
obligation to revise or update this release to reflect events or
circumstances after the date hereof.
ChromaDex Investor Relations Contact: Andrew
Johnson, Director of Investor Relations 949-419-0288
andrewj@chromadex.com
ChromaDex Public Relations Contact: Breah
Ostendorf, Director of Marketing 949-537-4103
breaho@chromadex.com
ChromaDex (NASDAQ:CDXC)
Historical Stock Chart
From Mar 2024 to Apr 2024
ChromaDex (NASDAQ:CDXC)
Historical Stock Chart
From Apr 2023 to Apr 2024